The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.

MLA

Greenhawt, Matthew, et al. “The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.” The Journal of Allergy and Clinical Immunology. In Practice, vol. 9, no. 10, Oct. 2021, pp. 3546–67. EBSCOhost, https://doi.org/10.1016/j.jaip.2021.06.006.

APA

Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., Alqurashi, W., Arkwright, P., Baldwin, J. L., Ben-Shoshan, M., Bernstein, J., Bingemann, T., Blumchen, K., Byrne, A., Bognanni, A., Campbell, D., Campbell, R., Chagla, Z., Chan, E. S., … Golden, D. B. K. (2021). The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. The Journal of Allergy and Clinical Immunology. In Practice, 9(10), 3546–3567. https://doi.org/10.1016/j.jaip.2021.06.006

Chicago

Greenhawt, Matthew, Elissa M Abrams, Marcus Shaker, Derek K Chu, David Khan, Cem Akin, Waleed Alqurashi, et al. 2021. “The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.” The Journal of Allergy and Clinical Immunology. In Practice 9 (10): 3546–67. doi:10.1016/j.jaip.2021.06.006.